Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α- tetrahydroprogesterone (allopregnanolone) availability?
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (9) , 865-873
- https://doi.org/10.1016/s0006-3223(98)00070-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Fluoxetine in the Treatment of Premenstrual DysphoriaNeuropsychopharmacology, 1997
- Pregnenolone sulfate antagonizes dizocilpine amnesiaNeuroReport, 1995
- Distribution of 3α-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humansThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Pharmacology of Neurosteroid Biosynthesis. Role of the Mitochondrial DBI Receptor (MDR) ComplexAnnals of the New York Academy of Sciences, 1994
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Regionaland Interspecies Differences in Brain Progesterone MetabolismJournal of Neurochemistry, 1993
- Stimulation of Brain Pregnenolone Synthesis by Mitochondrial Diazepam Binding Inhibitor Receptor Ligands In VivoJournal of Neurochemistry, 1993
- Diazepam binding inhibitor (DBI): A peptide with multiple biological actionsLife Sciences, 1991
- Neurosteroids: A new brain function?The Journal of Steroid Biochemistry and Molecular Biology, 1990
- Neurosteroids act on recombinant human GABAA receptorsNeuron, 1990